Latest Breaking News On - Bluerock therapeutics - Page 1 : comparemela.com

Bayer: BlueRock's Parkinson's Disease Cell Therapy Candidate Bemdaneprocel Gets FDA RMAT Designation

LEVERKUSEN (dpa-AFX) - German pharmaceutical and life sciences major Bayer AG (BAYZF.PK, BAYRY.PK, BYR.L) announced Thursday that its clinical stage cell therapy unit BlueRock Therapeutics LP's

Bluerock Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation For Parkinson'S Disease Cell Therapy Candidate Bemdaneprocel

.Regenerative

DAX Marginally Higher Ahead Of Eurozone Unemployment Data

German stocks were marginally higher on Thursday ahead of unemployment and economic confidence survey results from the euro area due later in the day. The benchmark DAX was up 24 points, or 0.

European Shares Rebound After Two Days Of Losses

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - European stocks were seeing modest gains on Thursday after two days of selling on inflation and interest-rate concerns. Unemployment across the eurozone has

Dow Likely To See Further Downside Amid Steep Drop By Salesforce